跳至主要内容
临床试验/NCT05238727
NCT05238727Unknown不适用

Effect of Volume Increase Compared to Supplemental 4% Articaine Buccal Infiltration on Mepivacaine Inferior Alveolar Nerve Block Success in Cases With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial

Cairo University0 个研究点目标入组 75 人开始时间: 2022年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
75
主要终点
Anesthetic success

研究概览

简要总结

To assess the anesthetic success of inferior alveolar nerve block (IANB), intraoperative pain intensity and need for supplemental anesthesia on administration of 1.8ml or 3.6ml 2% mepivacaine IANB, or 1.8ml 2% mepivacaine IANB plus 1.8ml 4% articaine buccal infiltration (BI) in mandibular molars with symptomatic irreversible pulpitis.

详细描述

Patients with moderate-to-severe preoperative pain related to mandibular molars with symptomatic irreversible pulpitis will be included. Patients receive 1.8 ml, 3.6 ml 2% mepivacaine IANB, or 1.8ml 2% mepivacaine IANB plus 1.8ml 4% articaine BI. Anesthetic success of inferior alveolar nerve block, intraoperative pain intensity and need for supplemental anesthesia will be assessed during treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in good health (ASA Class I, II).
  • Age between 18-60 years old.
  • Males or females.
  • Mandibular molar teeth diagnosed with symptomatic irreversible pulpitis.
  • Patients who can understand NRS scale and sign the informed consent.

排除标准

  • Patients who had used any type of analgesic medication during the preceding 8 hours before the treatment.
  • Pregnant or nursing females.
  • Patients with a contraindication for the use of mepivacaine, articaine or any used drug or material.

研究组 & 干预措施

1.8 ml mepivacaine IANB

Active Comparator

干预措施: 1.8 ml mepivacaine hydrochloride (Drug)

3.6 ml mepivacaine IANB

Experimental

干预措施: 3.6 ml mepivacaine hydrochloride (Drug)

1.8 ml mepivacaine IANB plus 1.8 ml articaine BI

Experimental

干预措施: 1.8 ml mepivacaine hydrochloride IANB plus 1.8 ml articaine hydrochloride BI (Drug)

结局指标

主要结局

Anesthetic success

时间窗: During the treatment

Will be recorded by 11-point numerical rating scale (NRS) consisting of numbers from 0 through 10. 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain". Success will be defined as no to mild pain.

次要结局

  • Intraoperative pain(During the treatment)
  • Need for supplemental anesthesia(During the treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Reham Anwar Mohammed El Said Sleem

Ms

Cairo University

相似试验